Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FOXC1 and SOX10 in Estrogen Receptor-Low Positive/HER2-Negative Breast Cancer: Potential Biomarkers for the Basal-like Phenotype Prediction.

Archives of pathology & laboratory medicine - 1 Apr 2024

Li Ming, Zhou Shuling, Lv Hong, Cai Mengyuan, Wan Xiaochun, Lu Hongfen, Shui Ruohong, Yang Wentao

Abstract excerpt

CONTEXT.—: Breast cancer with low (1%-10%) estrogen receptor (ER) expression (ER-low positive) constitutes a small portion of invasive breast cancers, and the treatment strategy for these tumors remains debatable. OBJECTIVE.—: To characterize the features and outcomes of ER-low positive patients, and clarify the clinical significance of FOXC1 and SOX10 expression in ER-low positive/HER2-negative tumors. DESIGN.—:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erb-b2 Receptor Tyrosine Kinases

Share to Forkhead Transcription Factors

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to RNA, Messenger

Share to SOXE Transcription Factors

Source

Identifiers

PMID: 37406289
DOI: 10.5858/arpa.2022-0370-OA

Genes

FOXC1
SOX10

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FOXC1 and SOX10 in Estrogen Receptor-Low Positive/HER2-Negative Breast Cancer: Potential Biomarkers for the Basal-like Phenotype Prediction.PMID 37406289Read ↗

Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profilingSemantic proximity Read ↗

Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traitsSemantic proximity Read ↗

Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traits.Semantic proximity Read ↗

SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancerSemantic proximity Read ↗

Clinicopathological significance of Sox10 expression in triple-negative breast carcinomaSemantic proximity Read ↗

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expressionSemantic proximity Read ↗

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.Semantic proximity Read ↗

Clinicopathological features and prognosis of HER2 low-expression breast cancer: a single-center retrospective studySemantic proximity Read ↗

The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 statusSemantic proximity Read ↗

Gene-Expression Analysis and the Basal-Like Breast Cancer SubtypeSemantic proximity Read ↗

Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.Semantic proximity Read ↗

Immunohistological Expression of SOX-10 in Triple-Negative Breast Cancer: A Descriptive Analysis of 113 SamplesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.